Cell Signaling & Oncology

Axon Ligands™ for Cell Signaling & Oncology Research

The signaling pathways controlling cell growth and differentiation are almost invariably altered in cancer. During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, and to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. These properties reflect alterations in the cellular signaling pathways that in normal cells control cell proliferation, motility, and survival. These interconnected pathways are being deciphered, but understanding the alterations that lead to cancer and correcting them is a substantial challenge. Among the key pathways are those controlling cell proliferation, which coordinate a response to the cellular environment, with the mTOR kinase as a critical node. Tumour development is influenced by infections and inflammation, and the complex role of the nuclear factor-B transcription factors is being unravelled. Expansion of tumour cells depends on nutrient supply and vascularization, which is orchestrated by the transcription factor known as HIF. And the metastatic spread of primary tumours to other organs is facilitated by many signaling pathways[1],[2].

Cell Signaling and Oncology products Library

For your convenience, you can order a library of all of our Cell Signaling and Oncology research related products. Make your personal library by cherry picking products of your interest from our comprehensive list (>800 products), or order all together not to miss any. The libraries will be shipped as 10 mM solutions (in DMSO, 250 µL of each selected Axon Ligand™) on a 96-well microtiter plate with a clear map of its contents.

Simply download our comprehensive list of epigenetics products below (Microsoft Excel (.xls)), check the products to be included, and return your list to order the library of your preference.

Axon Ligands™ for Epigenetic research   Axon 5051 - Cell signaling and Oncology Library.xls                   

 

[1] A. Eccleston, R. Dhand. Signalling in cancer. Nature 441, 423, editorial note
[2] G.S. Martin. Cell signaling and cancer. Cancer Cell. 2003 Sep;4(3):167-74.

Items 1 to 15 of 37 total

per page
Page:
  1. 1
  2. 2
  3. 3
Axon ID Name Description From price
2385 WZ 4003 Specific dual inhibitor of NUAK1 (ARK5) and NUAK2 (SNARK) €90.00
2628 TMS CYP1B1 inhibitor that induces apoptosis in human cancer cells €75.00
1960 Tariquidar Inhibitor of P-glycoprotein (P-gp, ABCB1) €135.00
2124 TAK 700 Potent and highly selective inhibitor of 17,20-lyase (CYP17A1) €105.00
1136 SU 6656 SRC kinase inhibitor €120.00
2743 STK16-IN-1 ATP-competitive STK16 inhibitor €125.00
1865 Stemregenin 1 Aryl hydrocarbon receptor (AHR) antagonist €105.00
2778 Squarunkin A Selective UNC119–cargo interaction inhibitor €125.00
1701 Shz-1 Stem cell differentiating agent; Nkx2.5 inducer €95.00
1871 Pifithrin-α hydrobromide Inhibitor of p53 protein €95.00
2600 PF 06463922 Potent, orally available and brain-penetrant ALK/ROS1 selective inhibitor €105.00
2026 PF 04981517 Inhibitor of Cytochrome P450 3A4 (CYP3A4) €110.00
1416 NVP-TAE684 NPM-ALK inhibitor €70.00
1892 NM-PP1, 1- Potent tyrosine kinase inhibitor (TKI) of multiple targets (Src, Fyn, Abl, CDK, Trk) €95.00
1941 MLR 1023 Selective allosteric activator of Lyn kinase €95.00

Items 1 to 15 of 37 total

per page
Page:
  1. 1
  2. 2
  3. 3
Please wait...